Silymarin ascending multiple oral dosing phase I study in noncirrhotic patients with chronic hepatitis C.

Journal of clinical pharmacology

Volumn 50, Issue 4, 2010, Pages 434-449

  Hawke, Roy L ^a   Schrieber, Sarah J ^b   Soule, Tedi A ^b   Wen, Zhiming ^b   Smith, Philip C ^b   Reddy, K Rajender ^b   Wahed, Abdus S ^b   Belle, Steven H ^b   Afdhal, Nezam H ^b   Navarro, Victor J ^b   Berman, Josh ^b   Liu, Qi Ying ^b   Doo, Edward ^b   Fried, Michael W ^b   SyNCH Trial Group, ^b  

^a University of North Carolina   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

SILYMARIN; VIRUS RNA;

ADULT; ARTICLE; BLOOD; CLINICAL TRIAL; COHORT ANALYSIS; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; LIVER CIRRHOSIS; MALE; MIDDLE AGED; MULTICENTER STUDY; ORAL DRUG ADMINISTRATION; PHASE 1 CLINICAL TRIAL; RANDOMIZED CONTROLLED TRIAL;

ADMINISTRATION, ORAL; ADULT; COHORT STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FEMALE; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; LIVER CIRRHOSIS; MALE; MIDDLE AGED; RNA, VIRAL; SILYMARIN;

MLCS; MLOWN;

EID: 77957265017     PISSN: None     EISSN: 15524604     Source Type: Journal    
DOI: 10.1177/0091270009347475     Document Type: Article

References (0)